Massimo L.
- Country
- Italy
- Department
- Urologia e andrologia
Research Overview
Data & Insights
Has run more than one trial at 19 of 92 partner sites.
Specializations
Urologic Oncology
The investigator specializes in treating non-muscle invasive bladder cancer, with particular focus on high-risk and intermediate-risk cases. Their research encompasses innovative therapeutic approaches for patients with FGFR gene alterations in bladder cancer.
- Bladder Cancer Management
- FGFR-Positive Cancer Treatment
- Intravesical Therapy
Key interests include developing treatment options for patients who have received Bacillus Calmette-Guérin (BCG) therapy and exploring alternatives for those ineligible for radical cystectomy.
Personalized Medicine
The investigator focuses on developing targeted treatments for patients with specific genetic profiles, particularly those with FGFR-positive bladder cancers. Their work involves evaluating novel therapeutic approaches through direct bladder instillation methods.
- Genetic-Based Treatment Selection
- Targeted Therapy Development
- Treatment Response Assessment
Their research emphasizes improving disease-free survival through personalized treatment approaches.
Alternative Treatment Strategies
The investigator evaluates novel therapeutic options for patients who require alternatives to standard treatments. Their work includes investigating new intravesical chemotherapy approaches and comparing different treatment modalities.
- Treatment Alternative Development
- Comparative Treatment Studies
- Non-Surgical Interventions
Research focuses on providing options for patients who cannot undergo or choose not to pursue radical cystectomy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.